Fortress Biotech, Inc. (Nasdaq: FBIO) ('Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ('Cyprium”), ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress") and its majority-owned subsidiary, Cyprium Therapeutics, Inc. ("Cyprium"), today announced that Cyprium entered ...

Key market opportunities in healthcare finance solutions include increasing outpatient care, fintech integration, demand for flexible financing, adoption of predictive analytics, and growing chronic ...

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, ...

Kane Biotech Inc. (TSX- V:KNE) ('Kane Biotech” or 'Kane”) announces the publication of an article on its revyve® Antimicrobial wound gel in the International Wound Journal. The article 'Wound Healing ...

AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable.

Healthcare Investors reported an 8.43% NAV return for Q4 2025. Read the full analysis for insights on sector strategy and ...

Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech" or the "Company") today announces that it has signed non-exclusive distribution/sales agreements for ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2025 Earnings Call Transcript February 17, 2026 Krystal Biotech, Inc. beats earnings ...

Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ...

The FDA is flagging a high-risk issue with blood glucose monitors manufactured by Trividia Health that the company says is tied to 114 serious injuries and one death since the devices’ launch 12 years ...